GlassScriptPhysician profile
Kellie A Cummings
NPI 1407480551
$3,764.54
in general payments reported to CMS, 2019-2025
15 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,388 · 2022: $817 · 2023: $554 · 2024: $462 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031 · Education: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.82 |
| Education | $527.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $834.69 | 2021-2025 | Opzelura |
| Leo Pharma INC. | $774.36 | 2021-2025 | Adbry, Anzupgo |
| Abbvie INC. | $618.66 | 2021-2023 | |
| Janssen Biotech, INC. | $410.25 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $246.55 | 2021-2023 | |
| Ucb, INC. | $182.72 | 2021-2022 | |
| Amgen INC. | $171.46 | 2021-2022 | |
| Pfizer INC. | $103.49 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2024 | |
| Genzyme Corporation | $86.19 | 2021-2024 | |
| Lilly USA, LLC | $72.61 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $64.65 | 2022-2024 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $41.93 | 2022-2023 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.89 | 2021 | |
| Vyne Pharmaceuticals INC. | $21.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.